Drug: CORTANCYL Injury: Febrile bone marrow aplasia Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125479621 | CORTANCYL | Febrile bone marrow aplasia | ROCHE | 70.00 YR | F | 52 KG | 20160712 | FR |
125623761 | CORTANCYL | Febrile bone marrow aplasia | TEVA | 70.17 YR | F | 52 KG | 20160715 | FR |
125657011 | CORTANCYL | Febrile bone marrow aplasia | PFIZER | 70.00 YR | F | 52 KG | 20160718 | FR |
126780122 | CORTANCYL | Febrile bone marrow aplasia | PFIZER | 63.00 YR | M | 76 KG | 20160831 | FR |
126869741 | Cortancyl | Febrile bone marrow aplasia | BAXTER | 63.70 YR | M | 76 KG | 20160826 | FR |
126899601 | CORTANCYL | Febrile bone marrow aplasia | TEVA | 63.74 YR | M | 76 KG | 20160826 | FR |
126912491 | CORTANCYL | Febrile bone marrow aplasia | MYLAN | 0.00 | 0 | 20160826 | FR |
Total Records: 7 Number of Pages: 1